Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
Sequencing the tumor genome using next-generation sequencing (NGS) is providing an unparalleled insight into the pathogenesis and progression of the disease. Much of the current focus of NGS in cancer is on defining mutations in the tumor genome at disease presentation, and these findings are central to understanding the molecular mechanisms that underlie pathogenesis.
1188-1191
Weston-Bell, N.
c99c8c28-519f-4c3e-bd8c-679995a0472e
Gibson, J.
855033a6-38f3-4853-8f60-d7d4561226ae
John, M.
99d82961-4c85-4568-8e11-b50946b0f2d3
Ennis, S.
7b57f188-9d91-4beb-b217-09856146f1e9
Pfeifer, S.
60f7f04e-d918-46f1-92a1-5305ed360e0f
Cezard, T.
df878ab5-11f4-4c7d-b897-8b1c9fa83ce7
Ludwig, H.
ff5c3f7b-d92f-411f-9e6a-53aa8fca4335
Collins, Andrew
7daa83eb-0b21-43b2-af1a-e38fb36e2a64
Zojer, N.
5dec9dcd-c973-44e7-80c5-28b6f62713f9
Sahota, S. S.
66c1457f-cba2-4c49-9c8c-fcee0748b6b8
April 2013
Weston-Bell, N.
c99c8c28-519f-4c3e-bd8c-679995a0472e
Gibson, J.
855033a6-38f3-4853-8f60-d7d4561226ae
John, M.
99d82961-4c85-4568-8e11-b50946b0f2d3
Ennis, S.
7b57f188-9d91-4beb-b217-09856146f1e9
Pfeifer, S.
60f7f04e-d918-46f1-92a1-5305ed360e0f
Cezard, T.
df878ab5-11f4-4c7d-b897-8b1c9fa83ce7
Ludwig, H.
ff5c3f7b-d92f-411f-9e6a-53aa8fca4335
Collins, Andrew
7daa83eb-0b21-43b2-af1a-e38fb36e2a64
Zojer, N.
5dec9dcd-c973-44e7-80c5-28b6f62713f9
Sahota, S. S.
66c1457f-cba2-4c49-9c8c-fcee0748b6b8
Weston-Bell, N., Gibson, J., John, M., Ennis, S., Pfeifer, S., Cezard, T., Ludwig, H., Collins, Andrew, Zojer, N. and Sahota, S. S.
(2013)
Exome sequencing in tracking clonal evolution in multiple myeloma following therapy.
Leukemia, 27 (5), .
(doi:10.1038/leu.2012.287).
(PMID:23147253)
Abstract
Sequencing the tumor genome using next-generation sequencing (NGS) is providing an unparalleled insight into the pathogenesis and progression of the disease. Much of the current focus of NGS in cancer is on defining mutations in the tumor genome at disease presentation, and these findings are central to understanding the molecular mechanisms that underlie pathogenesis.
This record has no associated files available for download.
More information
e-pub ahead of print date: 9 October 2012
Published date: April 2013
Organisations:
Cancer Sciences, Human Development & Health
Identifiers
Local EPrints ID: 345396
URI: http://eprints.soton.ac.uk/id/eprint/345396
ISSN: 0887-6924
PURE UUID: 78a1c498-49cc-41e9-b3ae-d4080e74475d
Catalogue record
Date deposited: 20 Nov 2012 11:27
Last modified: 15 Mar 2024 03:17
Export record
Altmetrics
Contributors
Author:
N. Weston-Bell
Author:
M. John
Author:
S. Pfeifer
Author:
T. Cezard
Author:
H. Ludwig
Author:
N. Zojer
Author:
S. S. Sahota
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics